Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
G GENITO URINARY SYSTEM AND SEX HORMONES
G04 UROLOGICALS
G04B UROLOGICALS
G04BE Drugs used in erectile dysfunction
G04BE08 Tadalafil
D02008 Tadalafil (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Genitourinary Agents
Benign Prostatic Hypertrophy Agents
Tadalafil
D02008 Tadalafil (JAN/USP/INN)
Respiratory Tract/Pulmonary Agents
Pulmonary Antihypertensives
Phosphodiesterase-5 (PDE5) Inhibitors
Tadalafil
D02008 Tadalafil (JAN/USP/INN)
Sexual Disorder Agents
Sexual Disorder Agents (Male)
Tadalafil
D02008 Tadalafil (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
219 Miscellaneous
2190 Miscellaneous
D02008 Tadalafil (JAN/USP/INN)
25 Urogenital and anal organ agents
259 Miscellaneous
2590 Miscellaneous
D02008 Tadalafil (JAN/USP/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01509 Phosphodiesterase V inhibitor
D02008 Tadalafil
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D02008 Tadalafil
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Phosphodiesterases
PDE5
D02008 Tadalafil (JAN/USP/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D02008
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D02008
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02008
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02008
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D02008